Trials / Completed
CompletedNCT00718653
Effects of Antioxidants on Human Macular Pigments
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- National Eye Institute (NEI) · NIH
- Sex
- All
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Age-related macular degeneration (AMD) is the leading cause of blindness in the United States. Low dietary intake or low blood levels of lutein and zeaxanthin, which are the only pigments found in the macular region of the human retina, has been associated with an increased risk for AMD. We have reported that the dietary supplementation of lutein and zeaxanthin can increase the macular pigments (MP) of the eye. MP effectively absorbs blue light as well as quenches reactive oxygen species (ROS). Green tea polyphenols are also effective scavenger of ROS in vitro. Our goal is to elucidate how to effectively increase MP by physiologic levels of antioxidant supplementation. We hypothesize that lutein and tea polyphenols protect the macula of the eye by increasing MP carotenoids effectively through an antioxidant mechanism.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lutein | Lutein (12 mg/d) |
| DIETARY_SUPPLEMENT | Lutein plus green tea extract | lutein (12 mg/d) plus green tea extract (200 mg/d) |
Timeline
- Start date
- 2004-09-01
- Primary completion
- 2007-12-01
- Completion
- 2007-12-01
- First posted
- 2008-07-21
- Last updated
- 2009-03-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00718653. Inclusion in this directory is not an endorsement.